We have now closed our doors.
For 15 years, Cenix BioScience conducted contract research and developed new reagent technologies focused on a wide array of preclinical cell-based and in vivo applications of RNAi-based gene silencing and other related methods.
Please see Comments/Posts for a final message from all of us.